[Cancer Management and Research] Based on these study findings, researchers present 4 prediction models developed to determine risk of malignancy in subsolid and solid lung nodules that are 15 mm or smaller and 15 to 30 mm.
[Cancer Management and Research] Researchers present a simple classification method for assessing fatigue, which is proven to be a prognostic marker of TTP and OS in patients with HCC.
[Blood and Lymphatic Cancer: Targets and Therapy] Although this retrospective analysis determined that ibrutinib was not associated with higher mortality in older patients with CLL, it did find greater intolerance with an increased number of early deaths in elderly patients treated with ibrutinib.
[Cancer Management and Research] This study explores the preference of colorectal cancer patients for port catheters (PCs) through comparing the costs and complications between peripherally inserted central venous catheters and PCs.
[Cancer Management and Research] This retrospective observational study sought to describe the characteristics and clinical outcomes of nosocomial infections in hospitalized patients with GI cancer.
[Lung Cancer: Targets and Therapy] A review of neuroendocrine tumors of the lung and treatment rationale, as well as an in-depth review of the use of everolimus for the treatment of these tumors.
[Cancer Management and Research] A review of past and ongoing trials using ipilimumab-nivolumab combination therapy for metastatic renal cell carcinoma.
Three risk factors were found to be predictive of infectious complications in older patients with gastric cancer undergoing surgical resection.
[OncoTargets and Therapy] Researchers outline promising findings for the use of polatuzumab vedotin for patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
[OncoTargets and Therapy] While multimodal treatment can be curative in select cases of r/r pediatric sarcoma, treatment refractoriness remains a tremendous hurdle for clinicians.